Skip to main content
# Title Department Research Year
41 COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challenges 2023
42 New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 2023
43 Ratiometric fluorometric determination of sulfide using graphene quantum dots and self‑assembled thiolate‑capped gold nanoclusters triggered by aluminum Department of Pharmaceutical Analytical Chemistry 2023
44 Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells Department of Industrial Pharmacy 2023
45 Phage therapy, a salvage treatment for multidrug-resistant bacteria causing infective endocarditis 2023
46 Selective fluorescence turn-on detection of combination cisplatin–etoposide chemotherapy based on N-CDs/GSH-CuNCs nanoprobe† Department of Pharmaceutical Analytical Chemistry 2023
47 A feasible HPTLC method for concurrent quantitation of allopurinol-montelukast co-therapy in plasma and evaluation of their hepatic and renal effects in rats: Analytical, biochemical, and histopathological study Department of Pharmaceutical Analytical Chemistry 2023
48 Design, synthesis, and antiproliferative properties of new 1, 2, 3-triazole-carboximidamide derivatives as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2023
49 HPTLC/MS and HPTLC/UV for monitoring of degradation behavior of some β-Lactam antibiotics mixtures under ambient storage conditions Department of Pharmaceutical Analytical Chemistry 2023
50 Synthesis and characterization of magnetic Ag–Fe3O4@polymer hybrid nanocomposite systems with promising antibacterial application Department of Industrial Pharmacy 2023